SAFETY AND EFFICACY OF MIPOMERSEN ADMINISTERED AS ADD-ON THERAPY IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND HIGH CARDIOVASCULAR RISK

被引：13
|
作者：
Cromwell, William C.
Thomas, Gregory S.
Boltje, Ingrid
Chin, Wai
Davidson, Michael
机构：
[1] Presbyterian Cardiovasc Inst, Charlotte, NC USA
[2] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 57卷 / 14期
关键词：
D O I：
10.1016/S0735-1097(11)60504-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E504 / E504
页数：1
相关论文
共 50 条
  • [21] The efficacy and safety of ruxolitinib as an add-on therapy to corticosteroids for patients with severe checkpoint inhibitor pneumonitis
    Xu, Yan
    Huang, Hui
    Gao, Xiaoxing
    Liu, Xiaoyan
    Chen, Ruxuan
    Chen, Minjiang
    Zhao, Jing
    Zhong, Wei
    Gao, Junzhen
    Wang, Mengzhao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] EFFICACY AND SAFETY EVALUATION OF LORECLEZOLE AS ADD-ON TREATMENT IN THERAPY-RESISTANT EPILEPSY PATIENTS
    RENTMEESTER, T
    HULSMAN, J
    EPILEPSY RESEARCH, 1991, 8 (02) : 166 - 169
  • [23] Safety and efficacy of doxazosin as an "add-on" antihypertensive therapy in mild to moderate heart failure patients
    Spoladore, Roberto
    Roccaforte, Rosa
    Fragasso, Gabriele
    Gardini, Chiara
    Palloshi, Altin
    Cuko, Amarild
    Arioli, Francesco
    Salerno, Anna
    Margonato, Alberto
    ACTA CARDIOLOGICA, 2009, 64 (04) : 485 - 491
  • [24] Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk
    Thomas, Gregory S.
    Cromwell, William C.
    Ali, Shariq
    Chin, Wai
    Flaim, JoAnn D.
    Davidson, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (23) : 2178 - 2184
  • [25] Efficacy of levetiracetam as an add-on therapy in patients with startle epilepsy
    Ciftci, F.
    Alpay, K.
    Gurses, C.
    Bebek, N.
    Baykan, B.
    Gokyigit, A.
    EPILEPSIA, 2006, 47 : 134 - 134
  • [26] Efficacy and Safety of Mipomersen in Patients with Familial Hypercholesterolemia and Inadequately Controlled LDL-C Levels
    Ballantyne, Christie
    Catapano, Alberico L.
    Davidson, Michael
    Mittleman, Robert
    Moriarty, Patrick M.
    Santos, Raul D.
    Sensinger, Charlotte
    de Banerjee, Samarita
    Singleton, Walter
    Baker, Brenda F.
    Soran, Handrean
    Tsimikas, Sotorios
    Kastelein, John J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36
  • [27] Triple therapy with saxagliptin and dapagliflozin add-on to metformin: safety of dual add-on versus sequential add-on
    Garcia-Sanchez, R.
    Del Prato, S.
    Matthaei, S.
    Iqbal, N.
    Hansen, L.
    Johnsson, E.
    Chen, H.
    Chin, A. J.
    Mathieu, C.
    DIABETOLOGIA, 2015, 58 : S356 - S356
  • [28] The clinical efficacy and safety of levetiracetam add-on therapy for child refractory epilepsy
    Chen, J.
    Liu, X. -M.
    Yue, X.
    Chen, S. -Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (12) : 2689 - 2694
  • [29] Efficacy and Safety of Add-On Vildagliptin to Metformin in Comparison to Uptitrating Metformin Therapy
    Kim, Nan Hee
    Sung, Yeon-Ah
    Ahn, Chul Woo
    Park, Seok Won
    Lim, Soo
    Kim, Chul Hee
    Kim, Dong Sun
    Shin, Young Goo
    Ahn, Kyu Jeung
    Kim, Jae Hyeon
    Baik, Sei Hyun
    DIABETES, 2012, 61 : A297 - A297
  • [30] Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA
    Duan, Weijia
    Ou, Xiaojuan
    Wang, Xiaoming
    Wang, Yu
    Zhao, Xinyan
    Wang, Qianyi
    Wu, Xiaoning
    Zhang, Wei
    Ma, Hong
    You, Hong
    Jia, Jidong
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2018, 110 (09) : 557 - 563
12345